-
BMS and Pfizer Alliance urge people to tune in to Afib to reduce Stroke Risk
worldpharmanews
December 06, 2017
Bristol-Myers Squibb and Pfizer Alliance, National Stroke Association and iHeartMedia today released "Adjusting AFib to Document Stroke Risk"
-
Pfizer enters into agreement to develop and commercialize CRESEMBA? in China and Asia
worldpharmanews
December 04, 2017
Pfizer and Brasilia Pharma Ltd. reached an agreement to provide CRESEMBA exclusive development and commercialization rights in a number of countries in China and the Asia Pacific region
-
The €34 million project for assessing liver disease
biospectrumasia
November 24, 2017
The €34 million project is co-ordinated by Newcastle University, working closely with the lead EFPIA partner, Pfizer Ltd.
-
Pfizer and Genentech Duke it Out in Court Over Herceptin Biosimilar Patents
biospace
November 23, 2017
Genentech,?a?Roche?company,?sued?Pfizer?in a federal court in Wilmington, Delaware, over Pfizer’s biosimilar for Genentech’s Herceptin.
-
Pfizer in fight with states over their intent to use its drugs for executions
fiercepharma
November 21, 2017
Pfizer is in a tug of war with several states that intend to use some of its drugs to carry out executions.
-
Pfizer’s Sutent kidney cancer win should give it a boost, at least until I-O treatments arrive
fiercepharma
November 20, 2017
Pfizer’s old dog Sutent has shown it has one more trick to perform as a renal cancer treatment before being passed up by the new breed of immuno-oncology drugs.
-
Pfizer Q2 net dips to Rs 111 cr
expressbpd
November 14, 2017
Pfizer’s offer for the San Francisco, California-based Medivation goes far beyond the company’s market value of $11.1 billion. Medivation shares closed at $67.16 in Friday trading (Reuters)
-
BMS-Pfizer Alliance to unveil real-world data analyses - cost, safety and comparative effectiveness
worldpharmanews
November 13, 2017
Bristol-Myers Squibb and Pfizer plan to release actual data on the results of direct oral anticoagulation in patients with non-valvular atrial fibrillation Using the U.S. Medicare Database
-
Pfizer renews 'Know Pneumonia' campaign with myth-busting creative
fiercepharma
November 09, 2017
Pfizer has relaunched its “Know Pneumonia” disease awareness campaign with a myths-and-facts approach.
-
With new FDA nod, Roche's Alecensa set to challenge Pfizer, Novartis in first-line lung cancer
fiercepharma
November 08, 2017
Roche's lung cancer drug Alecensa had been relegated to patients who'd failed on treatment with one of its rivals, but a new FDA nod is changing all that.
ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
Pharma Sources Insight July 2025
